New User? Sign Up | Sign In

Insider Trading - Lyell Immunopharma Inc. (LYEL)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

LYEL Insider Trading Transactions for Lyell Immunopharma Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-21
Purchase
2021-06-23
5:33 pm
Lyell Immunopharma Inc. LYEL FRIEDMAN CATHY
Director
17,648 $17 $300,016 17,648
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-06-21
Conversion
2021-06-23
5:33 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL FRIEDMAN CATHY
Director
3,765,842 $0 3,765,842
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:33 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL FRIEDMAN CATHY
Director
3,765,842 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:35 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL Bishop Hans Edgar
Director
546,806 $0 3,546,806
(Direct)
View
2021-06-21
Conversion
2021-06-23
5:35 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL Bishop Hans Edgar
Director
546,806 $0 0
(Direct)
View
2021-06-21
Conversion
2021-06-23
5:36 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL Klausner Richard
Chairman
3,765,842 $0 3,765,842
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:36 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL Klausner Richard
Chairman
3,765,842 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:38 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL NELSEN ROBERT
Director
10% Owner
18,206,358 $0 18,206,358
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:38 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL NELSEN ROBERT
Director
10% Owner
18,206,358 $0 18,206,358
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:38 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL NELSEN ROBERT
Director
10% Owner
17,771,216 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:38 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL NELSEN ROBERT
Director
10% Owner
17,771,216 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:38 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL NELSEN ROBERT
Director
10% Owner
435,142 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:38 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL NELSEN ROBERT
Director
10% Owner
435,142 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:42 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL ARCH Venture Partners IX LLC
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
18,206,358 $0 18,206,358
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:42 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL ARCH Venture Partners IX LLC
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
18,206,358 $0 18,206,358
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:42 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL ARCH Venture Partners IX LLC
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
17,771,216 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:42 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL ARCH Venture Partners IX LLC
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
17,771,216 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:42 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL ARCH Venture Partners IX LLC
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
435,142 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:42 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL ARCH Venture Partners IX LLC
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
435,142 $0 0
(Indirect)
View
2021-06-21
Conversion
2021-06-23
6:14 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL GLAXOSMITHKLINE PLC
10% Owner
30,253,188 $0 30,253,188
(Indirect)
View
2021-06-21
Conversion
2021-06-23
6:14 pm
N/A
N/A
Lyell Immunopharma Inc. LYEL GLAXOSMITHKLINE PLC
10% Owner
30,253,188 $0 0
(Indirect)
View